LIM
GILD icon

Leavell Investment Management’s Gilead Sciences GILD Stock Holding History

Leavell Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Sell
2,673
-55
-2% -$7.25K 0.01% 512
2026
Q1 		$380K Buy
2,728
+291
+12% +$40.8K 0.02% 468
2025
Q4 		$299K Sell
2,437
-666
-21% -$80.9K 0.01% 499
2025
Q3 		$344K Sell
3,103
-140
-4% -$15.9K 0.01% 482
2025
Q2 		$360K Sell
3,243
-893
-22% -$95K 0.02% 465
2025
Q1 		$463K Sell
4,136
-734
-15% -$75.7K 0.02% 402
2024
Q4 		$450K Buy
4,870
+395
+9% +$35.6K 0.02% 392
2024
Q3 		$375K Sell
4,475
-1,166
-21% -$89K 0.02% 437
2024
Q2 		$387K Sell
5,641
-3,018
-35% -$201K 0.02% 396
2024
Q1 		$634K Buy
8,659
+4,708
+119% +$362K 0.04% 320
2023
Q4 		$320K Buy
3,951
+38
+1% +$2.96K 0.02% 394
2023
Q3 		$293K Hold
3,913
– – 0.02% 391
2023
Q2 		$302K Hold
3,913
– – 0.02% 395
2023
Q1 		$325K Sell
3,913
-390
-9% -$32.3K 0.02% 378
2022
Q4 		$369K Sell
4,303
-755
-15% -$59.8K 0.03% 350
2022
Q3 		$312K Buy
5,058
+190
+4% +$12K 0.02% 367
2022
Q2 		$301K Sell
4,868
-122
-2% -$7.55K 0.02% 368
2022
Q1 		$297K Buy
4,990
+500
+11% +$32K 0.02% 366
2021
Q4 		$326K Buy
4,490
+132
+3% +$9.09K 0.02% 367
2021
Q3 		$304K Buy
4,358
+667
+18% +$46.9K 0.02% 346
2021
Q2 		$239K Hold
3,691
– – 0.02% 362
2021
Q1 		$239K Buy
3,691
+140
+4% +$9.03K 0.02% 362
2020
Q4 		$207K Hold
3,551
– – 0.02% 366
2020
Q3 		$224K Hold
3,551
– – 0.02% 347
2020
Q2 		$273K Buy
3,551
+616
+21% +$47.2K 0.03% 321
2020
Q1 		$219K Buy
+2,935
New +$203K 0.03% 328
2017
Q2 		– Sell
-11,273
Closed -$766K – 371
2017
Q1 		$766K Sell
11,273
-8,865
-44% -$623K 0.1% 183
2016
Q4 		$1.44M Sell
20,138
-6,214
-24% -$462K 0.2% 125
2016
Q3 		$2.08M Buy
26,352
+1,794
+7% +$146K 0.31% 99
2016
Q2 		$2.05M Sell
24,558
-4,102
-14% -$364K 0.3% 98
2016
Q1 		$2.63M Buy
28,660
+442
+2% +$39.9K 0.39% 77
2015
Q4 		$2.85M Buy
28,218
+343
+1% +$35.7K 0.42% 67
2015
Q3 		$2.74M Buy
27,875
+1,750
+7% +$194K 0.43% 63
2015
Q2 		$3.06M Sell
26,125
-150
-0.6% -$16.4K 0.47% 61
2015
Q1 		$2.58M Buy
26,275
+650
+3% +$66K 0.39% 75
2014
Q4 		$2.42M Hold
25,625
– – 0.37% 80
2014
Q3 		$2.73M Hold
25,625
– – 0.43% 69
2014
Q2 		$2.13M Hold
25,625
– – 0.34% 94
2014
Q1 		$1.82M Buy
25,625
+1,030
+4% +$80.8K 0.3% 104
2013
Q4 		$1.85M Buy
24,595
+95
+0.4% +$6.62K 0.31% 98
2013
Q3 		$1.54M Buy
24,500
+500
+2% +$29.9K 0.28% 100
2013
Q2 		$1.23M Buy
+24,000
New +$1.25M 0.23% 117

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Leavell Investment Management's GILD Position: Q2 2026 in Review

Leavell Investment Management reduced its Gilead Sciences (GILD) stake by 2% in Q2 2026, selling an estimated $7.25K and leaving 2,673 shares worth $338K. The position accounts for 0.01% of the portfolio, ranked #512.

Leavell Investment Management first reported a position in GILD in Q2 2013 and has held it in 42 quarters since. The position peaked at $3.06M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Leavell Investment Management held 2,673 shares of Gilead Sciences worth $338K as of Q2 2026.
  • Leavell Investment Management sold 55 Gilead Sciences shares in Q2 2026, an estimated $7.25K.
  • Gilead Sciences made up 0.01% of Leavell Investment Management's portfolio in Q2 2026, its #512 holding.
  • Leavell Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 42 quarters since.
  • Leavell Investment Management's Gilead Sciences position peaked at $3.06M in Q2 2015.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.